Literature DB >> 30610309

Atlantoaxial Fixation for Treatment of Chiari Formation and Syringomyelia with No Craniovertebral Bone Anomaly: Report of an Experience with 57 Cases.

Atul Goel1,2, Amol Kaswa3, Abhidha Shah3.   

Abstract

AIM: In this paper we evaluate the role of atlantoaxial instability in the pathogenesis of Chiari formation type I and the role of atlantoaxial stabilization for treatment of this condition in cases with no obvious bone malformation in the region of the craniovertebral junction. MATERIALS, METHODS AND
RESULTS: During the period from January 2010 to July 2016, we identified 57 cases of Chiari formation where there was no bone malformation or evidence of craniovertebral junction instability that could be diagnosed on the basis of an abnormal increase in the atlantodental interval on dynamic imaging. Forty-eight of these patients had syringomyelia. The average duration of follow-up was 42 months. There were 30 males and 27 females in the series. The ages of the patients ranged from 4 to 57 years. The Japanese Orthopaedic Association (JOA), visual analogue scale (VAS) and Goel clinical grading systems were used to assess the patients' clinical status. Atlantoaxial instability was diagnosed on the basis of vertical mobility of the odontoid process on dynamic radiographs, facetal malalignment on imaging or direct bone handling during the surgical procedure. Surgical treatment was achieved using atlantoaxial fixation. Foramen magnum decompression or syrinx manipulation was not done. All patients had immediate postoperative and sustained clinical symptomatic recovery. A reduction in the size of the syrinx was observed in ten patients and regression of tonsillar herniation was observed in 12 of 23 cases in which postoperative magnetic resonance imaging (MRI) was possible.
CONCLUSION: Atlantoaxial instability is the prime factor in the genesis of Chiari formation even when there is no bone abnormality in the craniovertebral junction.

Entities:  

Keywords:  Atlantoaxial instability; Chiari formation; Foramen magnum decompression; Syringomyelia

Mesh:

Year:  2019        PMID: 30610309     DOI: 10.1007/978-3-319-62515-7_15

Source DB:  PubMed          Journal:  Acta Neurochir Suppl        ISSN: 0065-1419


  6 in total

Review 1.  The management of Chiari malformation type 1 and syringomyelia in children: a review of the literature.

Authors:  Veronica Saletti; Mariangela Farinotti; Paola Peretta; Luca Massimi; Palma Ciaramitaro; Saba Motta; Alessandra Solari; Laura Grazia Valentini
Journal:  Neurol Sci       Date:  2021-09-30       Impact factor: 3.307

2.  Surgical Management of Chiari Malformations: Preliminary Results of Surgery According to the Mechanisms of Ptosis of the Brain Stem and Cerebellum.

Authors:  Misao Nishikawa; Paolo A Bolognese; Roger W Kula; Hiromichi Ikuno; Toshihiro Takami; Kenji Ohata
Journal:  J Neurol Surg B Skull Base       Date:  2019-09-30

3.  Pathogenesis and Classification of Chiari Malformation Type I Based on the Mechanism of Ptosis of the Brain Stem and Cerebellum: A Morphometric Study of the Posterior Cranial Fossa and Craniovertebral Junction.

Authors:  Misao Nishikawa; Paolo A Bolognese; Roger W Kula; Hiromichi Ikuno; Kenji Ohata
Journal:  J Neurol Surg B Skull Base       Date:  2019-09-30

4.  Surgical Management of Chiari Malformation Type I Associated with Syringomyelia: Outcome of Surgeries Based on the New Classification and Study of Cerebrospinal Fluid Dynamics.

Authors:  Misao Nishikawa; Toru Yamagata; Kentarou Naito; Noritsugu Kunihiro; Hiroaki Sakamoto; Mistuhiro Hara; Kenji Ohata; Takeo Goto
Journal:  J Clin Med       Date:  2022-08-04       Impact factor: 4.964

5.  Chiari malformation type 1: are we doing less with more? Illustrative case.

Authors:  Giuseppe Talamonti; Erika Ferrari; Giuseppe D'Aliberti
Journal:  J Neurosurg Case Lessons       Date:  2021-02-08

6.  Diagnosis and treatment of Chiari malformation type 1 in children: the International Consensus Document.

Authors:  Luca Massimi; Paola Peretta; Alessandra Erbetta; Alessandra Solari; Mariangela Farinotti; Palma Ciaramitaro; Veronica Saletti; Massimo Caldarelli; Alexandre Casagrande Canheu; Carlo Celada; Luisa Chiapparini; Daniela Chieffo; Giuseppe Cinalli; Federico Di Rocco; Marika Furlanetto; Flavio Giordano; George Jallo; Syril James; Paola Lanteri; Christian Lemarchand; Martina Messing-Jünger; Cecilia Parazzini; Giovanna Paternoster; Gianluca Piatelli; Maria A Poca; Prab Prabahkar; Federica Ricci; Andrea Righini; Francesco Sala; Juan Sahuquillo; Marcus Stoodley; Giuseppe Talamonti; Dominic Thompson; Fabio Triulzi; Mino Zucchelli; Laura Valentini
Journal:  Neurol Sci       Date:  2021-06-07       Impact factor: 3.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.